NDC 51991-351

LACOSAMIDE

Lacosamide

LACOSAMIDE is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Breckenridge Pharmaceutical, Inc.. The primary component is Lacosamide.

Product ID51991-351_21d8300b-b6d1-4a99-ac67-7fa92c1cc809
NDC51991-351
Product TypeHuman Prescription Drug
Proprietary NameLACOSAMIDE
Generic NameLacosamide
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2022-03-18
Marketing CategoryANDA /
Application NumberANDA204921
Labeler NameBreckenridge Pharmaceutical, Inc.
Substance NameLACOSAMIDE
Active Ingredient Strength200 mg/1
Pharm ClassesDecreased Central Nervous System Disorganized Electrical Activity [PE]
DEA ScheduleCV
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 51991-351-05

500 TABLET, FILM COATED in 1 BOTTLE (51991-351-05)
Marketing Start Date2022-03-18
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 51991-351-05 [51991035105]

LACOSAMIDE TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA204921
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-06-15
Marketing End Date2016-06-16

NDC 51991-351-06 [51991035106]

LACOSAMIDE TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA204921
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-06-15
Marketing End Date2016-06-16

Drug Details

NDC Crossover Matching brand name "LACOSAMIDE" or generic name "Lacosamide"

NDCBrand NameGeneric Name
0121-0992LacosamideLacosamide
0121-1984LacosamideLacosamide
0121-2976LacosamideLacosamide
0121-3968LacosamideLacosamide
63850-0055LacosamideLacosamide
63850-0053LacosamideLacosamide
63850-0054LacosamideLacosamide
63850-0056LacosamideLacosamide
65162-912LacosamideLacosamide
0131-1810Vimpatlacosamide
0131-2470Vimpatlacosamide
0131-2477Vimpatlacosamide
0131-2478Vimpatlacosamide
0131-2479Vimpatlacosamide
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.